Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 33 (6) , 789-797
- https://doi.org/10.1016/0090-6980(87)90107-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Binding of a radioiodinated 13‐azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different speciesBritish Journal of Pharmacology, 1986
- Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548)Thrombosis Research, 1986
- Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle.Circulation, 1985
- Synthesis of thromboxane receptor antagonists with the potential to radiolabel with 125ITetrahedron Letters, 1984
- Ligand binding to thromboxane receptors on human platelets: correlation with biological activityBritish Journal of Pharmacology, 1983
- COMPARISON OF THE ACTIONS OF U‐46619, A PROSTAGLANDIN H2‐ANALOGUE, WITH THOSE OF PROSTAGLANDIN H2 AND THROMBOXANE A2 ON SOME ISOLATED SMOOTH MUSCLE PREPARATIONSBritish Journal of Pharmacology, 1981
- The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374) ? Equipotent to PGI2 in vitroNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
- Some biological effects of prostaglandin endoperoxide analogsLife Sciences, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- A Simplex Method for Function MinimizationThe Computer Journal, 1965